Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma

Andrea Rinaldi, Ivo Kwee, Monica Taborelli, Cristina Largo, Silvia Uccella, Vittoria Martin, Giulia Poretti, Gianluca Gaidano, Giuseppe Calabrese, Giovanni Martinelli, Luca Baldini, Giancarlo Pruneri, Carlo Capella, Emanuele Zucca, Finbarr E. Cotter, Juan C. Cigudosa, Carlo V. Catapano, Maria G. Tibiletti, Francesco Bertoni

Research output: Contribution to journalArticle

154 Citations (Scopus)

Abstract

Among B-cell lymphomas mantle cell lymphoma (MCL) has the worst prognosis. By using a combination of genomic and expression profiling (Affymetrix GeneChip Mapping 10k Xba131 and U133 set), we analysed 26 MCL samples to identify genes relevant to MCL pathogenesis and that could represent new therapeutic targets. Recurrent genomic deletions and gains were detected. Genes were identified as overexpressed in regions of DNA gain on 3q, 6p, 8q, 9q, 16p and 18q, including the cancer genes BCL2 and MYC. Among the transcripts with high correlation between DNA and RNA, we identified SYK, a tyrosine kinase involved in B-cell receptor signalling. SYK was amplified at DNA level, as validated by fluorescence in situ hybridisation (FISH) analysis, and overexpressed at both RNA and protein levels in the JeKo-1 cell line. Low-level amplification, with protein overexpression of Syk was demonstrated by FISH in a small subset of clinical samples. After treatment with low doses of the Syk inhibitor piceatannol, cell proliferation arrest and apoptosis were induced in the cell line overexpressing Syk, while cells expressing low levels of Syk were much less sensitive. A combination of genomic and expression profiling suggested Syk inhibition as a new therapeutic strategy to be explored in lymphomas.

Original languageEnglish
Pages (from-to)303-316
Number of pages14
JournalBritish Journal of Haematology
Volume132
Issue number3
DOIs
Publication statusPublished - Feb 2006

Fingerprint

Mantle-Cell Lymphoma
Protein-Tyrosine Kinases
B-Lymphocytes
Fluorescence In Situ Hybridization
DNA
RNA
Cell Line
Neoplasm Genes
B-Cell Lymphoma
Genes
Lymphoma
Proteins
Therapeutics
Cell Proliferation
Apoptosis

Keywords

  • 9q
  • Affymetrix
  • Isochromosome
  • Piceatannol
  • Syk

ASJC Scopus subject areas

  • Hematology

Cite this

Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. / Rinaldi, Andrea; Kwee, Ivo; Taborelli, Monica; Largo, Cristina; Uccella, Silvia; Martin, Vittoria; Poretti, Giulia; Gaidano, Gianluca; Calabrese, Giuseppe; Martinelli, Giovanni; Baldini, Luca; Pruneri, Giancarlo; Capella, Carlo; Zucca, Emanuele; Cotter, Finbarr E.; Cigudosa, Juan C.; Catapano, Carlo V.; Tibiletti, Maria G.; Bertoni, Francesco.

In: British Journal of Haematology, Vol. 132, No. 3, 02.2006, p. 303-316.

Research output: Contribution to journalArticle

Rinaldi, A, Kwee, I, Taborelli, M, Largo, C, Uccella, S, Martin, V, Poretti, G, Gaidano, G, Calabrese, G, Martinelli, G, Baldini, L, Pruneri, G, Capella, C, Zucca, E, Cotter, FE, Cigudosa, JC, Catapano, CV, Tibiletti, MG & Bertoni, F 2006, 'Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma', British Journal of Haematology, vol. 132, no. 3, pp. 303-316. https://doi.org/10.1111/j.1365-2141.2005.05883.x
Rinaldi, Andrea ; Kwee, Ivo ; Taborelli, Monica ; Largo, Cristina ; Uccella, Silvia ; Martin, Vittoria ; Poretti, Giulia ; Gaidano, Gianluca ; Calabrese, Giuseppe ; Martinelli, Giovanni ; Baldini, Luca ; Pruneri, Giancarlo ; Capella, Carlo ; Zucca, Emanuele ; Cotter, Finbarr E. ; Cigudosa, Juan C. ; Catapano, Carlo V. ; Tibiletti, Maria G. ; Bertoni, Francesco. / Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. In: British Journal of Haematology. 2006 ; Vol. 132, No. 3. pp. 303-316.
@article{b9434cf06c86499b8ad097371900fbad,
title = "Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma",
abstract = "Among B-cell lymphomas mantle cell lymphoma (MCL) has the worst prognosis. By using a combination of genomic and expression profiling (Affymetrix GeneChip Mapping 10k Xba131 and U133 set), we analysed 26 MCL samples to identify genes relevant to MCL pathogenesis and that could represent new therapeutic targets. Recurrent genomic deletions and gains were detected. Genes were identified as overexpressed in regions of DNA gain on 3q, 6p, 8q, 9q, 16p and 18q, including the cancer genes BCL2 and MYC. Among the transcripts with high correlation between DNA and RNA, we identified SYK, a tyrosine kinase involved in B-cell receptor signalling. SYK was amplified at DNA level, as validated by fluorescence in situ hybridisation (FISH) analysis, and overexpressed at both RNA and protein levels in the JeKo-1 cell line. Low-level amplification, with protein overexpression of Syk was demonstrated by FISH in a small subset of clinical samples. After treatment with low doses of the Syk inhibitor piceatannol, cell proliferation arrest and apoptosis were induced in the cell line overexpressing Syk, while cells expressing low levels of Syk were much less sensitive. A combination of genomic and expression profiling suggested Syk inhibition as a new therapeutic strategy to be explored in lymphomas.",
keywords = "9q, Affymetrix, Isochromosome, Piceatannol, Syk",
author = "Andrea Rinaldi and Ivo Kwee and Monica Taborelli and Cristina Largo and Silvia Uccella and Vittoria Martin and Giulia Poretti and Gianluca Gaidano and Giuseppe Calabrese and Giovanni Martinelli and Luca Baldini and Giancarlo Pruneri and Carlo Capella and Emanuele Zucca and Cotter, {Finbarr E.} and Cigudosa, {Juan C.} and Catapano, {Carlo V.} and Tibiletti, {Maria G.} and Francesco Bertoni",
year = "2006",
month = "2",
doi = "10.1111/j.1365-2141.2005.05883.x",
language = "English",
volume = "132",
pages = "303--316",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "3",

}

TY - JOUR

T1 - Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma

AU - Rinaldi, Andrea

AU - Kwee, Ivo

AU - Taborelli, Monica

AU - Largo, Cristina

AU - Uccella, Silvia

AU - Martin, Vittoria

AU - Poretti, Giulia

AU - Gaidano, Gianluca

AU - Calabrese, Giuseppe

AU - Martinelli, Giovanni

AU - Baldini, Luca

AU - Pruneri, Giancarlo

AU - Capella, Carlo

AU - Zucca, Emanuele

AU - Cotter, Finbarr E.

AU - Cigudosa, Juan C.

AU - Catapano, Carlo V.

AU - Tibiletti, Maria G.

AU - Bertoni, Francesco

PY - 2006/2

Y1 - 2006/2

N2 - Among B-cell lymphomas mantle cell lymphoma (MCL) has the worst prognosis. By using a combination of genomic and expression profiling (Affymetrix GeneChip Mapping 10k Xba131 and U133 set), we analysed 26 MCL samples to identify genes relevant to MCL pathogenesis and that could represent new therapeutic targets. Recurrent genomic deletions and gains were detected. Genes were identified as overexpressed in regions of DNA gain on 3q, 6p, 8q, 9q, 16p and 18q, including the cancer genes BCL2 and MYC. Among the transcripts with high correlation between DNA and RNA, we identified SYK, a tyrosine kinase involved in B-cell receptor signalling. SYK was amplified at DNA level, as validated by fluorescence in situ hybridisation (FISH) analysis, and overexpressed at both RNA and protein levels in the JeKo-1 cell line. Low-level amplification, with protein overexpression of Syk was demonstrated by FISH in a small subset of clinical samples. After treatment with low doses of the Syk inhibitor piceatannol, cell proliferation arrest and apoptosis were induced in the cell line overexpressing Syk, while cells expressing low levels of Syk were much less sensitive. A combination of genomic and expression profiling suggested Syk inhibition as a new therapeutic strategy to be explored in lymphomas.

AB - Among B-cell lymphomas mantle cell lymphoma (MCL) has the worst prognosis. By using a combination of genomic and expression profiling (Affymetrix GeneChip Mapping 10k Xba131 and U133 set), we analysed 26 MCL samples to identify genes relevant to MCL pathogenesis and that could represent new therapeutic targets. Recurrent genomic deletions and gains were detected. Genes were identified as overexpressed in regions of DNA gain on 3q, 6p, 8q, 9q, 16p and 18q, including the cancer genes BCL2 and MYC. Among the transcripts with high correlation between DNA and RNA, we identified SYK, a tyrosine kinase involved in B-cell receptor signalling. SYK was amplified at DNA level, as validated by fluorescence in situ hybridisation (FISH) analysis, and overexpressed at both RNA and protein levels in the JeKo-1 cell line. Low-level amplification, with protein overexpression of Syk was demonstrated by FISH in a small subset of clinical samples. After treatment with low doses of the Syk inhibitor piceatannol, cell proliferation arrest and apoptosis were induced in the cell line overexpressing Syk, while cells expressing low levels of Syk were much less sensitive. A combination of genomic and expression profiling suggested Syk inhibition as a new therapeutic strategy to be explored in lymphomas.

KW - 9q

KW - Affymetrix

KW - Isochromosome

KW - Piceatannol

KW - Syk

UR - http://www.scopus.com/inward/record.url?scp=33644851486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644851486&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2005.05883.x

DO - 10.1111/j.1365-2141.2005.05883.x

M3 - Article

VL - 132

SP - 303

EP - 316

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -